Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,557.56
(
-0.74%
)
US TECH 100
23,452.60
(
-1.13%
)
Dow Jones
45,807.07
(
-0.47%
)
Brent Oil
106.25
(
1.74%
)
Bitcoin
69,916.00
(
0.02%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 221639

Friday, 10/26/2018 11:09:45 AM

Friday, October 26, 2018 11:09:45 AM

Post# of 257262

BMY—My hunch based on the growth of yervoy (after some decline) is that combination therapy in melanoma - which is not SOC - is gaining traction simply based on more comfort with the opdivo and yervoy launch in RCC (especially given the much lower dosing used in renal)...

BMY agrees with you!

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today